Article Type
Changed
Fri, 04/05/2019 - 10:41
Display Headline
DTC test for BRCA mutations: What to tell patients who inquire

Resources

US Food & Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6, 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm. Accessed August 8, 2018.

US Preventive Services Task Force. Final recommendation statement: BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. Available at:
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Accessed August 8, 2018.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Issue
The Journal of Family Practice - 67(9)
Publications
Topics
Page Number
audio
Sections
Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Author and Disclosure Information

Doug Campos-Outcalt, MD, MPA, is a member of the US Community Preventive Services Task Force, a clinical professor at the University of Arizona College of Medicine, and a senior lecturer with the University of Arizona College of Public Health. He’s also an assistant editor at The Journal of Family Practice.

The speaker reported no potential conflicts of interest relevant to this audiocast.

Resources

US Food & Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6, 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm. Accessed August 8, 2018.

US Preventive Services Task Force. Final recommendation statement: BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. Available at:
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Accessed August 8, 2018.

Resources

US Food & Drug Administration. FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. March 6, 2018. Available at: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm599560.htm. Accessed August 8, 2018.

US Preventive Services Task Force. Final recommendation statement: BRCA-related cancer: risk assessment, genetic counseling, and genetic testing. Available at:
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing. Accessed August 8, 2018.

Issue
The Journal of Family Practice - 67(9)
Issue
The Journal of Family Practice - 67(9)
Page Number
audio
Page Number
audio
Publications
Publications
Topics
Article Type
Display Headline
DTC test for BRCA mutations: What to tell patients who inquire
Display Headline
DTC test for BRCA mutations: What to tell patients who inquire
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 08/16/2018 - 10:15
Un-Gate On Date
Thu, 08/16/2018 - 10:15
Use ProPublica
CFC Schedule Remove Status
Thu, 08/16/2018 - 10:15
Hide sidebar & use full width
render the right sidebar.